The drug tirazepate GLP-1 is known to improve sleep apnea for people with both obstructive sleep apnea (OSA) and obesity, but not all patients benefit equally. Now, new research presented at the 2026 ATS International Conference reveals which patients are likely to get the best results from treatment.
Please follow and like us:
